RHPI:REGULATORY

Novo Nordisk says Wegovy heart benefits due to more than weight loss

by
Novo Nordisk says Wegovy heart benefits due to more than weight loss

A 0.25 mg injection pen of Novo Nordisk’s weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, September 1, 2023. REUTERS/Victoria Klesty/Illustration/File Photo Acquire Licensing Rights PHILADELPHIA, Nov 11 (Reuters) – Novo Nordisk (NOVOb.CO) on Saturday said the heart protective benefits of its wildly popular Wegovy obesity treatment are due to more … Read more

Lilly’s diabetes drug gets greenlight from UK watchdog

by
Lilly’s diabetes drug gets greenlight from UK watchdog

The logo of Lilly is seen on a wall of the Lilly France company unit, part of the Eli Lilly and Co drugmaker group, in Fegersheim near Strasbourg, France, February 1, 2018. Picture taken February 1, 2018. REUTERS/Vincent Kessler/File Photo Acquire Licensing Rights Sept 8 (Reuters) – Eli Lilly’s (LLY.N) diabetes drug Mounjaro has gained … Read more

Obesity drug data could boost companies’ case for US coverage

by
Obesity drug data could boost companies’ case for US coverage

[1/3]An overweight woman sits on a chair in Times Square in New York, May 8, 2012. America’s obesity epidemic is so deeply rooted that it will take dramatic and systemic measures – from overhauling farm policies and zoning laws to, possibly, introducing a soda tax – to fix it, the influential… Read more Aug 10 … Read more

Quest Diagnostics launches Alzheimer’s blood test for consumers

by
Quest Diagnostics launches Alzheimer’s blood test for consumers

CHICAGO, July 31 (Reuters) – Quest Diagnostics (DGX.N) on Monday launched the first direct-to-consumer blood test to detect abnormal levels of beta amyloid, a key Alzheimer’s disease protein that can appear years before dementia symptoms arise. The $399 test, called AD-Detect, uses the same technology as a blood test the company began selling for use … Read more